Finally, we got the data on the optimal anticoagulation intensity to prevent stroke in Asian patients with moderate to severe mitral valve stenosis, secondary to rheumatic heart disease.
bpspubs.onlinelibrary.wiley.âĶ
Great meeting with Assoc. Prof Surakit Nathisuwan at Mahidol University to explore ways DNDi and Mahidol can collaborate on dengue and hepatitis C, two urgent health issues in Thailand. Partnerships like this are key to advancing treatments and making a real impact on #NTDs
Happy to see a successful collaborative model to improve adherence to 2nd prevention medications in Thailand. Thanks to all involved.
Establishment of postâpercutaneous coronary intervention (postâPCI) clinic in Thailand - JACCP accpjournals.onlinelibrary.wâĶ
Pharmacist-led interventions resulted in a significant improvement in disease knowledge, medication adherence, and BP control in the Vietnamese context of practice and health system. buff.ly/4e5onGW
A significant milestone for #hepatitisC in Thailand as we sign the MoU of collaborative & licensing agreement for ravidasvir with @DNDi , @PharcoC , @mupharm & @MahidolU to help more of Thailand's #hepatitisC patients in need of treatment.
Glad to get this work out. The study shows how important it is to use the real performance of drugs in a particular health system, when performing cost-effectiveness analysis (CEA). SharedIt link:
rdcu.be/c4Q1Rlink.springer.com/article/10âĶ
It is such an exciting opportunity for the Faculty of Pharmacy, Mahidol University to be a cofounder of M Med Pharma Co., Ltd. We hope to bring high-quality health products and services to serve Thai people and beyond.
mmed.com (Thai language website)
A new bleeding risk prediction score developed for patients with mitral valve stenosis and mechanical heart valve, who are receiving warfarin, is now available. It is called "HEART-60 3" score. Cheers to the research team!
BPS Publications bpspubs.onlinelibrary.wiley.âĶ
'With climate change and the #COVID19 crisis, the situation is getting worse on treatment access. We need collaboration between countries... If we work together, we can take charge in finding solutions we need.'
@radzi_dr from @KKMPutrajaya at #GHS2022. #access2meds
Thanks to continuous investment of Thailand in building health databases. These databases can now be serve as valuable sources for real-world evidence research. This is an example of how it can be put to good use in evaluating drugs for heart attack.
thelancet.com/journals/lanwpâĶ
Such an honor for Mahidol University to get to work with DNDi to eradicate HCV in Thailand. Great discussion with Jean Michel Piedagnel who provides insights, experience and brilliant ideas. We are inspired!
Pharmacist intervention can provide a wide range of benefits in cardiovascular disease management, ranging from risk factor control, improvement in medication adherence and in some setting, reduction in morbidity and mortality.
BPS Publications bpspubs.onlinelibrary.wiley.âĶ